Calidi Biotherapeutics, Inc. (CLDI) Form 8-K — May 29, 2026
Calidi Biotherapeutics, Inc. (CLDI) filed an 8-K reporting the issuance of an amended and restated warrant to purchase up to 17,391,304 shares of common stock at an exercise price of $0.23 per share. The warrant was issued to an accredited investor in a private placement transaction, amending a warrant originally dated May 6, 2026. The amendment increases the Minimum Vesting Acquisition Amount from $500,000 to $1,000,000 and extends the Vesting Termination Date from July 8, 2026, to September 30, 2026.
Key figures
- Exercise Price
- 0.23
- Warrant Shares
- 17391304
- Minimum Vesting Acquisition Amount
- 1000000
- Prior Minimum Vesting Acquisition Amount
- 500000
- Vesting Termination Date
- September 30, 2026
- Prior Vesting Termination Date
- July 8, 2026
Price after filing
Close on the filing date to close N calendar days later (from $0.19). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.